Skip to main content
. 2004 Oct;48(10):3789–3793. doi: 10.1128/AAC.48.10.3789-3793.2004

TABLE 2.

Quinolone MICs for nalidixic acid-susceptible, nalidixic acid-resistant, and ciprofloxacin-resistant Salmonella isolates obtained by the agar dilution method

Antibiotic MIC (μg/ml) for:
Nalidixic acid-susceptible isolates (n = 62)
Nalidixic acid-resistant isolates (n = 124)
Ciprofloxacin-resistant isolatesa (n = 5)
50% 90% Range 50% 90% Range
Nalidixic acid 4 8 4-8 512 >1,024 128->1,024 >1,024
Norfloxacin 0.12 0.12 0.12 1 2 0.25-4 >16
Enrofloxacin 0.06 0.06 0.06 0.5 1 0.25-2 >32b
Ciprofloxacin 0.03 0.06 0.03-0.06 0.25 0.5 0.25-2.0 16
a

The five isolates were Salmonella serovar Typhimurium DT104.

b

Determined by Etest.